| Name | Title | Contact Details |
|---|
CellOxess is a Pennington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
eCare21`s mHealth application collects, compares and analyzes real-time information about users health and wellness. eCare21 integrates the efforts of families, doctors, nurses, volunteers, businesses – and seniors themselves to build a care model suitable for the 21st century. eCare21 seamlessly integrates with wearable and medical devices, Electronic Health Records and healthcare management systems, providing a single point continuous care solution for seniors.
Open Door Health Center is a Homestead, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Red Rock Behavioral Health Services is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.